Laura McWhinney, Author at ISR Market Research

Exploring the Integral Role of CMC in Small and Emerging Biopharma

By Laura McWhinneyManufacturing

The Chemistry, Manufacturing, and Controls Function In the dynamic world of biopharmaceuticals, small and emerging companies play a vital role in driving innovation and advancing groundbreaking therapies. While these companies often possess cutting-edge science and promising drug candidates, they may...

How Custom Brand Studies Can Help Your Company Succeed

By Laura McWhinneyBrand Health

In the fiercely competitive world of biopharmaceuticals, standing out from the crowd is essential. That’s where Industry Standard Research’s brand position market research comes into play, offering companies the key to standing out … in the good way. Understanding your...

Can’t Stop Us Now: CRO Growth Amid Uncertainty

By Laura McWhinneyClinical Trials

The world is flush with economic uncertainty, so this may come as a surprise: the CRO market has been experiencing steady growth. Even with a global pandemic, this growth trend is expected to continue. (See our just-published report 2023 CRO...

Advancing Clinical Research with Advanced Technology

By Laura McWhinneyClinical Trials, Technology

Technology advances so rapidly, it seems that adapting to innovative technology takes more time than it does to actually develop the technology. It was fewer than thirty years ago that we first heard those grating sounds of dial-up internet, connecting...

Win the Small and Emerging Sponsors’ Service Contracts

By Laura McWhinneyClinical Trials

Requests for proposals have been well-established and can help sponsors evaluate service providers. RFPs aren’t without effort, time, and evaluation to determine which provider is best. RFPs are a useful tool to decide which sponsor to pursue bids from and...

How to Make Your CRO Stand Out or Find that Perfect Fit

By Laura McWhinneyClinical Trials

Without safe and well-designed clinical trials, drug development would lack necessary direction and evaluation. The industry knows how valuable clinical trials are and so do we. Our reports explore the myriad facets of this dynamic and crucial process to provide...

Predictive Power of Perceived Leadership

By Laura McWhinneyClinical Trials

The Industry Standard Research CRO Benchmarking reports contain service provider experiences and perspectives from recent users in the biopharmaceutical sphere. This information can inform sponsor organizations to make more educated CRO selections for their Phase I, II, and III studies....

CDMO Performance on Service Provider Selection Criteria

By Laura McWhinneyManufacturing

2023 is the 12th year of Life Science Leader’s annual CDMO Leadership Awards, where contract manufacturers are recognized for their ability to deliver above and beyond the expectations of their drug innovator clients. The awards are the result of sponsor...

How Industry Benchmarks Can Inform CDMO Selection

By Laura McWhinneyManufacturing

Biopharmaceutical sponsor considerations when selecting a CDMO may include timelines, cost, regulatory requirements, capacity, quality, risks, and previous experience. To help sponsors better understand and prioritize development and manufacturing elements, ISR conducts four annual, manufacturing-specific benchmark studies that ask professionals...

Decentralized Clinical Trials: Evolving Post-Pandemic

By Laura McWhinneyArticles

Decentralized clinical trials (DCTs) are studies in which some or all trial-related activities are conducted at a location separate from the investigators’ primary site. DCTs’ numerous benefits include convenience and flexibility for patients, greater opportunities for patient recruitment, increased patient...